Reliance Capital Trustee Co Ltd- A/C Nippon India Arbitrage Fund
Institution · data to Jun 2020
Disclosed value
₹1,089 Cr
Jun 2020 closes
At current prices
…
Current holdings
3
Tracked since
Dec 2019
Portfolio value over time
Sum of disclosed holdings across all combined entities, valued at each quarter's closing price.
Current holdings (Jun 2020)
| Company | Holding | QoQ | Value |
|---|---|---|---|
| Aurobindo Pharma Ltd | 1.14% | NEW | ₹521 Cr |
| IndusInd Bank Ltd | 1.52% | flat | ₹466 Cr |
| NCC Ltd | 5.52% | NEW | ₹102 Cr |
Portfolio Summary
Jun 2020As of Jun 2020, Reliance Capital Trustee Co Ltd- A/C Nippon India Arbitrage Fund — an institution tracked through public shareholding filings — disclosed 3 holdings in Indian listed companies worth ₹1,089 crore. The same holdings-at-filing-value basis put it at ₹724 crore in Mar 2020 (+50.3%). Solomo carries these filings back to Dec 2019.
Largest disclosed positions in Jun 2020: Aurobindo Pharma Ltd (AUROPHARMA — 1.14% of the company, ₹521 crore); IndusInd Bank Ltd (INDUSINDBK — 1.52% of the company, ₹466 crore); NCC Ltd (NCC — 5.52% of the company, ₹102 crore).
Changes in the Jun 2020 filings: newly disclosed — Aurobindo Pharma Ltd, NCC Ltd. No longer disclosed after the previous quarter: Grasim Industries Ltd — which can mean a sale, a stake falling below the 1% disclosure line, or that name not filing this quarter.
| Quarter | Disclosed value | Change |
|---|---|---|
| Jun 2020 | ₹1,089 Cr | +50.3% |
| Mar 2020 | ₹724 Cr | −58.2% |
| Dec 2019 | ₹1,735 Cr | - |